Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Actos pioglitazone hcl endocrine data

Lancet published a meta-analysis of diabetes drugs Avandia rosiglitazone from GlaxoSmithKline plc (LSE:GSK; GSK, London, U.K.) and Actos pioglitazone from Takeda and Eli Lilly and Co. (LLY, Indianapolis, Ind.). The analysis, which looked at

Read the full 344 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers